Evidence map›Paper›PMID 36009248›Full record

ArticleAntioxidants (Basel, Switzerland)2022

Roméo Arago Dougué Kentsop, Roberto Consonni, Michela Alfieri, Marina Laura, Gianluca Ottolina, Iride Mascheretti, Monica Mattana

Open access · goldAbstract read
In one paragraph

Article in Antioxidants (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Stimulation of Lignan Production inMolecules (Basel, Switzerland) · 2022
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Roméo Arago Dougué KentsopInstitute of Agricultural Biology and Biotechnology, National Research Council, Via Bassini 15, 20133 Milan, Italy.ORCID 0000-0002-3389-4472
Roberto ConsonniInstitute of Chemical Sciences and Technologies "Giulio Natta", National Research Council, Via Corti 12, 20133 Milan, Italy.ORCID 0000-0003-0184-2384
Michela AlfieriInstitute of Chemical Sciences and Technologies "Giulio Natta", National Research Council, Via Corti 12, 20133 Milan, Italy.
Marina LauraCREA Research Centre for Vegetable and Ornamental Crops (CREA OF), Corso degli Inglesi 508, 18038 Sanremo, Italy.ORCID 0000-0001-8932-2337
Gianluca OttolinaInstitute of Chemical Sciences and Technologies "Giulio Natta", National Research Council, Via Corti 12, 20133 Milan, Italy.
Iride MascherettiInstitute of Agricultural Biology and Biotechnology, National Research Council, Via Bassini 15, 20133 Milan, Italy.
Monica MattanaInstitute of Agricultural Biology and Biotechnology, National Research Council, Via Bassini 15, 20133 Milan, Italy.
National Research Council · IT

Funding

Fondazione Cariplo 2016-0700
6 · The paper itself

Abstract

Plants synthesize specific secondary metabolites for survival, reproduction, environmental resilience, and defense. Among them, lignans are a class of polyphenols with several bioactive properties: chemopreventive, anti-inflammatory, antiviral, and antioxidant. These compounds are often extracted from field-grown plants with very low yields. To overcome these constraints, in vitro tissue cultures provide a tool to optimize large-scale production. Moreover, the use of elicitation to increase secondary metabolite production is gaining importance. The aim of this work was to develop adventitious (ARL) and hairy roots (HRL) from

Indexed as

antioxidant capacityelicitationflaxjusticidin Blignansprecursor feedingtissue cultures

Identifiers

PMID36009248
PMCPMC9404846
OpenAlexW4290466060

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.